APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,563,708 | -56.5% | 2,777 | -99.0% | 1.27% | -67.2% |
| Q2 2023 | $24,305,480 | +268.5% | 266,800 | +166.8% | 3.87% | +158.6% |
| Q1 2023 | $6,595,999 | -11.7% | 100,000 | -39.4% | 1.50% | +10.0% |
| Q2 2022 | $7,466,000 | -16.1% | 165,100 | -5.7% | 1.36% | +16.3% |
| Q1 2022 | $8,896,000 | -5.9% | 175,100 | -12.4% | 1.17% | -16.9% |
| Q4 2021 | $9,455,000 | -69.0% | 200,000 | -78.4% | 1.41% | -34.5% |
| Q3 2021 | $30,520,000 | -19.5% | 925,945 | +54.3% | 2.15% | -29.9% |
| Q2 2021 | $37,920,000 | +6611.5% | 600,000 | +3104.1% | 3.07% | +7378.0% |
| Q3 2020 | $565,000 | +718.8% | 18,726 | +780.8% | 0.04% | +720.0% |
| Q2 2020 | $69,000 | -95.1% | 2,126 | -95.9% | 0.01% | -95.2% |
| Q1 2020 | $1,396,000 | -91.4% | 52,126 | -90.1% | 0.10% | -96.0% |
| Q4 2019 | $16,145,000 | – | 527,253 | – | 2.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |